Matthew Ros - Insider Trading & Ownership

Entity
Individual
Location
C/O Epizyme, Inc., 400 Technology Square, Cambridge, Massachusetts
Summary
The estimated net worth of Matthew Ros is at least $553 K dollars as of June 13, 2024. Matthew Ros is the Director of Cogent Biosciences, Inc. and owns shares of Cogent Biosciences, Inc. (COGT) stock worth about $321 K. Matthew Ros is the Executive Vice President, Chief Strategy & Business Officer of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $232 K.
All Insider Reports
All Insider Reports

Ownership of Matthew Ros

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
COGT Cogent Biosciences, Inc. Director $321 K Jun 5, 2024
EPZM Epizyme, Inc. Executive Vice President, Chief Strategy & Business Officer $232 K Aug 16, 2021

Insider Transactions Reported by Matthew Ros:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership